Cargando…
Plasma levels of soluble TREM2 and neurofilament light chain in TREM2 rare variant carriers
BACKGROUND: Results from recent clinical studies suggest that cerebrospinal fluid (CSF) biomarkers that are indicative of Alzheimer’s disease (AD) can be replicated in blood, e.g. amyloid-beta peptides (Aβ(42) and Aβ(40)) and neurofilament light chain (NFL). Such data proposes that blood is a rich s...
Autores principales: | Ashton, Nicholas J., Suárez-Calvet, Marc, Heslegrave, Amanda, Hye, Abdul, Razquin, Cristina, Pastor, Pau, Sanchez-Valle, Raquel, Molinuevo, José L., Visser, Pieter Jelle, Blennow, Kaj, Hodges, Angela K., Zetterberg, Henrik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883551/ https://www.ncbi.nlm.nih.gov/pubmed/31779670 http://dx.doi.org/10.1186/s13195-019-0545-5 |
Ejemplares similares
-
Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer’s disease
por: Heslegrave, Amanda, et al.
Publicado: (2016) -
Cerebrospinal fluid neurogranin and TREM2 in Huntington’s disease
por: Byrne, Lauren M., et al.
Publicado: (2018) -
TREM2 brain transcript-specific studies in AD and TREM2 mutation carriers
por: Del-Aguila, Jorge L., et al.
Publicado: (2019) -
CSF concentrations of soluble TREM2 as a marker of microglial activation in HIV-1 infection
por: Gisslén, Magnus, et al.
Publicado: (2018) -
TREM2 splice isoforms generate soluble TREM2 species that disrupt long-term potentiation
por: Moutinho, Miguel, et al.
Publicado: (2023)